fingolimod hydrochloride has been researched along with Central Nervous System Toxoplasmosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diego Vélez, J; Enriquez-Marulanda, A; Luis Orozco, J; Maria Granados, A; Parrado, L; Quiñones, J; Valderrama-Chaparro, J | 1 |
1 other study(ies) available for fingolimod hydrochloride and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Cerebral toxoplasmosis in an MS patient receiving Fingolimod.
Topics: Adult; Brain; CD4 Lymphocyte Count; Diagnosis, Differential; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis; Toxoplasmosis, Cerebral | 2017 |